Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Fish Trial: Omega-3 for Post-CABG AF
NCT00446966Phase 4Completed
- Start
- Feb 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of eicosapentaenoic acid + docosahexaenoic acid in Atrial fibrillation (AFib) (2 arms). Primary endpoint: Number of Participants Who Developed Postoperative Atrial Fibrillation at 14 days. Started Feb 2007; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00446966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446966.